Comparison of maxillofacial space infection in diabetic and nondiabetic patients

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Dipesh D RaoC Bhasker Rao

Abstract

Orofacial space infections are common presentations in maxillofacial clinics even in the post-antibiotic era. One of the main factors determining the spread of infection is the host defense mechanism. Diabetes is one of the most common systemic illness suppressing the immunity of an individual and increasing their susceptibility to infections. This study was carried out to compare the spaces involved, the severity of infection, the virulent organism, the efficacy of empirical antibiotics, the length of hospital stay, and the complications encountered in the management of maxillofacial space infection of odontogenic origin in diabetic patients as compared with nondiabetic patients. A 4-year prospective study was carried out on patients with maxillofacial space infection of odontogenic origin. The patients were divided into 2 groups on the basis of presence or absence of diabetes. A total of 111 patients were identified out of which 31 were diabetic. The organisms commonly isolated were Streptococcus species with submandibular space being the most common space involved in both the groups. The empirical antibiotic used was amoxicillin plus clavulanic acid combined with metrogyl in 70.27% cases. Streptococcus species is still the m...Continue Reading

References

Sep 1, 1991·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·R H HaugA T Indresano
Dec 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·P Pozzilli, R D Leslie
Dec 1, 1996·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·E S PetersS T Sonis
Jun 2, 2000·American Journal of Otolaryngology·M K ChenH C Hsiao
Jan 28, 2003·Diabetes Care·Baiju R Shah, Janet E Hux
Jun 16, 2005·International Journal of Oral and Maxillofacial Surgery·J WangM A Pogrel
Aug 19, 2006·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Anthony J RegaVincent B Ziccardi
Jan 31, 2009·The British Journal of Oral & Maxillofacial Surgery·Laith Hussein Al-QamachiNicholas Hammersley
Jun 16, 2009·BMC Infectious Diseases·Galo PeraltaFátima Mateos
Aug 15, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Stevo MatijevićZorka Nonković

❮ Previous
Next ❯

Citations

Oct 15, 2013·Surgical Infections·Dimosthenis IgoumenakisGeorge Rallis
Mar 17, 2016·Annals of Maxillofacial Surgery·Andrew BothaCorne Postma
Oct 22, 2011·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Lingyan ZhengXin Guan
Mar 12, 2016·The Journal of Craniofacial Surgery·Xiaodong HanYang He
Jul 30, 2014·Emergency Medicine Australasia : EMA·Adrian F DeAngelisAlf L Nastri
Jun 9, 2012·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Paolo BoffanoCesare Gallesio
Mar 1, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·George C MathewSaurab Bither
Sep 5, 2015·Journal of the Korean Association of Oral and Maxillofacial Surgeons·Rahul D KamatOmkar Shetye
Nov 17, 2015·Journal of the Korean Association of Oral and Maxillofacial Surgeons·Jong-Won JangMoon-Young Kim
Dec 10, 2019·Maxillofacial Plastic and Reconstructive Surgery·Jinyoung ParkJae-Min Song
Apr 4, 2015·Journal of Maxillofacial and Oral Surgery·B Pramod KrishnaNitin Sethi
Oct 29, 2019·The Journal of Clinical Pediatric Dentistry·E BimsteinJ Katz
Nov 12, 2019·Lifetime Data Analysis·Marie-Therese PuthMoritz Berger
Jul 28, 2020·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Brian J ChristensenMishaun Sahebi
Nov 15, 2020·Irish Journal of Medical Science·Yunzhu QianPhimon Atsawasuwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.